# Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

> **NCT01252849** · NA · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 119 (actual)

## Conditions studied

- Primary Open Angle Glaucoma (POAG)

## Interventions

- **DEVICE:** iStent
- **DEVICE:** iStent
- **DEVICE:** iStent

## Key facts

- **NCT ID:** NCT01252849
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2019-10-08
- **Final completion:** 2019-10-08
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252849, "Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01252849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*